U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175428) titled 'Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation' on Sept. 09.
Brief Summary: This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation.
The aim of the study is to see how well REGN7508 and REGN9933 work in patients that get medicine for their atrial fibrillation. The bleeding effects of REGN7508 and REGN9933 will be compared to another medicine (ap...